Mylan has launched its generic version ... The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns ...

A suit against Novartis and Vitaris by Henrietta Lacks’ estate hinges on questions about the morality and legality of using ...

Pfizer and Mylan will continue to operate independent entities in Japan, but will collaborate on current and future generic products, sharing the costs and profits. The Japanese pharmaceutical ...

"The product was approved last month and AMGN ... alleged that a biosimilar version of Eylea proposed by a Viatris's Mylan Pharmaceuticals unit infringes patents for the drug, used to treat ...

In a report released today, Balaji Prasad from Barclays maintained a Sell rating on Viatris (VTRS – Research Report), with a price target ...

Mylan President Rajiv Malik and Emcure Pharmaceuticals CEO Satish Mehta are both named ... among drugmakers to fix prices and allocate customers for at least 15 generic products. Connecticut Attorney ...

Pfizer (PFL) announced it is spinning off its off-patent drug business and combining it with Real Money Stock of the Day Mylan (MYL) to create a new company. Cramer says that he's keeping an eye ...

Pharmaceutical company Viatris (VTRS 13.52%) reported third-quarter 2024 financial results on Thursday, Nov. 7, that topped ...

Viatris (VTRS) Company Description: Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and ...

(CN) — Global pharmaceutical giant Sanofi-Aventis asked the 10th ... Sanofi claims that rather than offer a better product, Mylan offered extensive discounts to insurers for exclusively covering the ...

The European Commission (EC) has fined pharmaceutical company Teva € ... The patent office decision would allow Mylan ...

Viatris is poised for appreciation with new product launches and a stronger balance sheet. Read why VTRS stock is a buy due ...